Role of Complete Blood Count, Coagulation, ABO Blood Group Parameters in Nephrolithiasis
Authors/Creators
- 1. Department of Biochemistry and Biotechnology, Parul Institute of Applied Sciences, Parul University, Limba, Waghodia, Vadodara-391760, Gujarat, India
- 2. Department of Biochemistry, Parul Institute of Medical Sciences and Research, Parul University, Limda, Waghodia,Vadodara-391460, Gujarat, India
- 3. Department of Business and Administration, Parul Institute of Management and Research, Parul University, Limda, Waghodia, Vadodara-391460, Gujarat, India
Description
Background: Complete blood count (CBC), Coagulation & ABO blood group parameters may associate with multiple diseases. Urinary stone disease is common public problem. Predictive value of CBC, Coagulation & ABO blood group parameters may be associated with effects of Nephrolithiasis disease. Objectives: To analyze the association between complete blood count (CBC), coagulation, ABO blood group parameters and Nephrolithiasis disease. Methodology: This study was done on the patients who were admitted to the urology (Surgical OPD) outpatient clinic or diagnosed with Nephrolithiasis disease in the emergency services department. There were 36 patients & 30 controls included in the study, the patients were confirmed by Multi detector CT (MDCT) urinography. Both patients and control subjects were studied for CBC, coagulation, ABO blood group parameters. Data of patients were retrieved from the hospital database and statistical analysis was performed. Results: An increase in Hb, MCH, MCHC, RDW, Neutrophiles, PT, WBC, Haematocrit, lymphocyte and decrease in RBC, MCV, Monocytes, Platelets, MPV, and PDW is statistically associated with urinary stone disease. In nephrolithiasis patients with B+ group is more affected. Conclusions: It is important to remember that CBC, Coagulation & ABO blood group parameters may support urinary stone disease and considering CBC & Coagulation results may be useful in the diagnosis of nephrolithiasis.
Abstract (English)
Background: Complete blood count (CBC), Coagulation & ABO blood group parameters may associate with multiple diseases. Urinary stone disease is common public problem. Predictive value of CBC, Coagulation & ABO blood group parameters may be associated with effects of Nephrolithiasis disease. Objectives: To analyze the association between complete blood count (CBC), coagulation, ABO blood group parameters and Nephrolithiasis disease. Methodology: This study was done on the patients who were admitted to the urology (Surgical OPD) outpatient clinic or diagnosed with Nephrolithiasis disease in the emergency services department. There were 36 patients & 30 controls included in the study, the patients were confirmed by Multi detector CT (MDCT) urinography. Both patients and control subjects were studied for CBC, coagulation, ABO blood group parameters. Data of patients were retrieved from the hospital database and statistical analysis was performed. Results: An increase in Hb, MCH, MCHC, RDW, Neutrophiles, PT, WBC, Haematocrit, lymphocyte and decrease in RBC, MCV, Monocytes, Platelets, MPV, and PDW is statistically associated with urinary stone disease. In nephrolithiasis patients with B+ group is more affected. Conclusions: It is important to remember that CBC, Coagulation & ABO blood group parameters may support urinary stone disease and considering CBC & Coagulation results may be useful in the diagnosis of nephrolithiasis.
Files
IJPCR,Vol14,Issue6,Article70.pdf
Files
(305.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:d7353248f16bbb871ad2d7770c2e5119
|
305.0 kB | Preview Download |
Additional details
Dates
- Accepted
-
2022-06-15
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/14/IJPCR,Vol14,Issue6,Article70.pdf
- Development Status
- Active
References
- 1. Chauhan CK, Joshi MJ, Vaidya ADB. Growth inhibitions of struvite crystals in the presence of herbal extract Boerhaaviadiffusa Linn. Am J Infectious Dise. 2009;5(3):177-86. 2. Srivastava T, Alon US. Pathophysiology of hypercalciuria. Pediatr. Nephrol. 2005;22:1659–73. 3. Johnson CM, Wilson DM, O'Fallon WM, Malek RS, Kurland LT. Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int. 1979;16(5):624–31.4. Khan SR. Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. J Urol. 2013; 189(3):803–11. 5. Boonla C, Wunsuwan R, Tungsanga K, Tosukhowong P. Urinary 8- hydroxydeoxyguanosine is elevated in patients with nephrolithiasis. Urol Res. 2007;35(4):185–91. 6. Mushtaq S, Siddiqui AA, Naqvi ZA, Rattani A, Talati J, Palmberg C, et al. Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones. ClinChimActa. 2007; 384(1-2):41–7. 7. Pierce CN, Larson DF. Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion. 2005 Mar;20(2):83-90. 8. Perkins SL. Greer JP, Foester J, Rodgers GM, Examination of the blood and bone marrow. Wintrobe's clinical hematology. 1998:9-35. 9. Ryan DH. Lichtman MA, Kipps TJ, Seligsohn U, et al, Examination of Blood Cells,eds. Williams Hematology. 8th ed. New York, NY: The McGrawHill Companies, Inc; 2010. Chap 2 10. Perkins SL, Hussong JW. Jones SL, Red Blood Cells ed. Clinical Laboratory Pearls. Philadelphia, PA: Lippincott Williams & Wilkins; 2001. 61-96. 11. Van Kimmenade RR, Mohammed AA, Uthamalingam S, van der Meer P, Felker GM, JanuzziJr JL. Red blood cell distribution width and 1‐year mortality in acute heart failure. European journal of heart failure. 2010 Feb;12(2):129-36. 12. Chen PC, Sung FC, Chien KL, Hsu HC, Su TC, Lee YT. Red blood cell distribution width and risk of cardiovascular events and mortality in a community cohort in Taiwan. Am J Epidemiol. 2010;171(2):214–20. 13. Sičaja M, Pehar M, Đerek L, Starčević B, Vuletić V, Romić Ž, Božikov V. Red blood cell distribution width as a prognostic marker of mortality in patients on chronic dialysis: a single center, prospective longitudinal study. Croatian medical journal. 2013 Feb 15;54(1):25-32. 14. Kim J, Kim K, Hyuk J, Hwan Y, Eui J, Yun T. Red blood cell distribution width as an independent predictor of all-cause mortality in out of hospital cardiac arrest. Resuscitation [Internet]. European Resuscitation Council, American Heart Association, Inc., and International Liaison Committee on Resuscitation. 2012;83(10):1248–52. 15. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Archives of pathology & laboratory medicine. 2009 Apr;133(4):628-32. 16. Pierce CN, Larson DF. Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion. 2005 Mar;20(2):83-90. 17. Van Kimmenade RR, Mohammed AA, Uthamalingam S, van der Meer P, Felker GM, JanuzziJr JL. Red blood cell distribution width and 1‐year mortality in acute heart failure. European journal of heart failure. 2010 Feb;12(2):129-36. 18. Sičaja M, Pehar M, Đerek L, Starčević B, Vuletić V, Romić Ž, Božikov V. Red blood cell distribution width as a prognostic marker of mortality in patients on chronic dialysis: a single center, prospective longitudinal study. Croatian medical journal. 2013 Feb 15;54(1):25-32. 19. Kim J, Kim K, Hyuk J, Hwan Y, Eui J, Yun T. Red blood cell distribution width as an independent predictor of all-cause mortality in out of hospital cardiac arrest. Resuscitation [Internet].European Resuscitation Council, American Heart Association, Inc., and International Liaison Committee on Resuscitation. 2012;83(10):1248–52. 20. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Archives of pathology & laboratory medicine. 2009 Apr;133(4):628-32 21. Pierce CN, Larson DF. Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion. 2005 Mar;20(2):83-90. 22. Sfoungaristos S, Kavouras A, Katafigiotis I, Perimenis P. Role of white blood cell and neutrophil counts in predicting spontaneous stone passage in patients with renal colic. BJU Int. 2012 Oct;110(8 Pt B):E339-45. 23. Sari ND, Notopuro PB, Hernaningsih Y. Hemoglobin, Hematocrit, Leukocyte, and Platelet Changes Due to Ultrafiltration hemodialysis in Chronic Kidney Disease Patients. Indonesian Journal of Clinical Pathology and Medical Laboratory. 2020;26(3):340-3. 24. Mao W, Wu J, Zhang Z, Xu Z, Xu B, Chen M. Neutrophil-lymphocyte ratio acts as a novel diagnostic biomarker for kidney stone prevalence and number of stones passed. Translational Andrology and Urology. 2021 Jan;10(1):77. 25. Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis. 1996 Mar 1;7(2):157-61. 26. Nnenna Adaeza N, Uchenna Emerible A, Abdullahi Nasiru, I, Babayo, A. and Uko EK. Evaluation of Prothrombin time and activated partial Thromboplastin time in hypersensitive patients attending a tertiary hospital calabar, Nigeria. Advances in Hematology.2014 Nov 16;2014. 27. Anand S. Association of ABO blood groups with incidence of renal lithiasis. Acta Genet Med Gemellol (Roma).1964 – April -13 : 167 28. Darmal, D. I., Khan, A., Ahmad, D. S., & Gowani, A. Frequency of Type II Diabetes Mellitus in ST Segment Elevated MI patients presented to French Medical Institute for Mothers and Children: A Cross Section Study. Journal of Medical Research and Health Sciences, 2022:5(6), 2023–2038.